367 related articles for article (PubMed ID: 32606678)
1. Targeted Nanobubbles Carrying Indocyanine Green for Ultrasound, Photoacoustic and Fluorescence Imaging of Prostate Cancer.
Wang Y; Lan M; Shen D; Fang K; Zhu L; Liu Y; Hao L; Li P
Int J Nanomedicine; 2020; 15():4289-4309. PubMed ID: 32606678
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional nanobubbles carrying indocyanine green and paclitaxel for molecular imaging and the treatment of prostate cancer.
Lan M; Zhu L; Wang Y; Shen D; Fang K; Liu Y; Peng Y; Qiao B; Guo Y
J Nanobiotechnology; 2020 Sep; 18(1):121. PubMed ID: 32883330
[TBL] [Abstract][Full Text] [Related]
3. Indocyanine Green-Loaded Nanobubbles Targeting Carbonic Anhydrase IX for Multimodal Imaging of Renal Cell Carcinoma.
Zhong C; Chen J; Ling Y; Liu D; Xu J; Wang L; Ge C; Jiang Q
Int J Nanomedicine; 2023; 18():2757-2776. PubMed ID: 37250472
[TBL] [Abstract][Full Text] [Related]
4. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
[TBL] [Abstract][Full Text] [Related]
5. Nanobody-loaded nanobubbles targeting the G250 antigen with ultrasound/photoacoustic/fluorescence multimodal imaging capabilities for specifically enhanced imaging of RCC.
Chen J; Li J; Zhong C; Ling Y; Liu D; Li X; Xu J; Liu Q; Guo Y; Wang L
Nanoscale; 2023 Dec; 16(1):343-359. PubMed ID: 38062769
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles.
Fan X; Guo Y; Wang L; Xiong X; Zhu L; Fang K
Int J Nanomedicine; 2016; 11():3939-50. PubMed ID: 27574424
[TBL] [Abstract][Full Text] [Related]
8. Efficacy evaluation and mechanism study on inhibition of breast cancer cell growth by multimodal targeted nanobubbles carrying AMD070 and ICG.
Shen D; Zhu L; Liu Y; Peng Y; Lan M; Fang K; Guo Y
Nanotechnology; 2020 Mar; 31(24):245102. PubMed ID: 32155591
[TBL] [Abstract][Full Text] [Related]
9. Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer.
Wang L; Li L; Guo Y; Tong H; Fan X; Ding J; Huang H
Prostate; 2013 Aug; 73(11):1147-58. PubMed ID: 23532872
[TBL] [Abstract][Full Text] [Related]
10. Magnetic polymeric nanobubbles with optimized core size for MRI/ultrasound bimodal molecular imaging of prostate cancer.
Zhu Y; Sun Y; Liu W; Guan W; Liu H; Duan Y; Chen Y
Nanomedicine (Lond); 2020 Dec; 15(30):2901-2916. PubMed ID: 33300812
[No Abstract] [Full Text] [Related]
11. Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging.
Peng Y; Zhu L; Wang L; Liu Y; Fang K; Lan M; Shen D; Liu D; Yu Z; Guo Y
Int J Nanomedicine; 2019; 14():9139-9157. PubMed ID: 32063704
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging.
Fan X; Wang L; Guo Y; Tu Z; Li L; Tong H; Xu Y; Li R; Fang K
PLoS One; 2015; 10(6):e0127419. PubMed ID: 26111008
[TBL] [Abstract][Full Text] [Related]
13. Quantification of extravasation and binding of PSMA-targeted nanobubbles by modelling the second-wave phenomenon.
Chen C; Perera R; Mischi M; Kolios M; Exner A; Turco S
Mol Imaging Biol; 2024 Apr; 26(2):253-263. PubMed ID: 38151581
[TBL] [Abstract][Full Text] [Related]
14. Photoacoustic signal enhancement in dual-contrast gastrin-releasing peptide receptor-targeted nanobubbles.
Zhao S; Lee L; Zhao Y; Liang NC; Chen YS
Front Bioeng Biotechnol; 2023; 11():1102651. PubMed ID: 36733960
[TBL] [Abstract][Full Text] [Related]
15. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer.
Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y
Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304
[TBL] [Abstract][Full Text] [Related]
16. In vivo photoacoustic molecular imaging of breast carcinoma with folate receptor-targeted indocyanine green nanoprobes.
Wang H; Liu C; Gong X; Hu D; Lin R; Sheng Z; Zheng C; Yan M; Chen J; Cai L; Song L
Nanoscale; 2014 Nov; 6(23):14270-9. PubMed ID: 25321626
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic modeling of PSMA-targeted nanobubbles for quantification of extravasation and binding in mice models of prostate cancer.
Chen C; Perera R; Kolios MC; Wijkstra H; Mischi M; Exner AA; Turco S
Med Phys; 2022 Oct; 49(10):6547-6559. PubMed ID: 36049109
[TBL] [Abstract][Full Text] [Related]
18. Real time ultrasound molecular imaging of prostate cancer with PSMA-targeted nanobubbles.
Perera RH; de Leon A; Wang X; Wang Y; Ramamurthy G; Peiris P; Abenojar E; Basilion JP; Exner AA
Nanomedicine; 2020 Aug; 28():102213. PubMed ID: 32348874
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific membrane antigen-targeted photoacoustic imaging of prostate cancer in vivo.
Zhang HK; Chen Y; Kang J; Lisok A; Minn I; Pomper MG; Boctor EM
J Biophotonics; 2018 Sep; 11(9):e201800021. PubMed ID: 29653029
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]